U.S. Invests $160M to Fast-Track Gene Therapy for Rare Diseases

A federal health agency just launched a $160 million program to develop personalized gene editing treatments for rare diseases, with clinical trials expected to start within three years.

Seven research teams are racing to bring hope to patients who've long waited for cures.